July 6, 2026 · Form 4 insider transaction
Carter Charles Ross bought 50,000 shares of Ovid Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Represents a restricted stock unit ("RSU") award. The RSUs will vest in two equal annual installments commencing on July 6, 2027, subject to the Reporting Person's continuous service through each such vesting date.; Each RSU represents a contingent right to receive one share of Common Stock.